光动力联合免疫检查点抑制剂治疗恶性肿瘤的研究进展

  • 打印
  • 收藏
收藏成功


打开文本图片集

中图分类号:R318.51 文献标志码:A 文章编号:0253-2395(2025)04-0815-14

Abstract:Malignant tumorsareseriouslyharmful tohumanhealth.Photodynamic therapyisanemerging therapywithadvantagesof lowtrauma,lowsideefectsandhighspatiotemporalcontrol.Ithasbeenwidelyusedintheclinical treatmentofmalignanttumors, butitislimitedtotetreamentoflocaltumorsFordistantmetastatictumoursorlsions tatcanotbepreciselylocated,hotody namictherapyasertailitatis.munothrapyspeciallmmuneckpointitors,asrought tetreatmntoflig nanttumors intoanewera.However,thelowexpressonlevelofimmunecheckpointintumorcelsanditsinsuffcientactivationof the host mmunesystemconstitute majorobstacles.Photodynamic therapycan activate the immune functionof the bodyand improve thetumor microenvironment, which provides apossibiltyforthe combinationof photodynamic therapyand immunotherapy. Nanoparticlescansimultaneouslyloadphotosensitizersandimmunecheckpointinhibitorstoachievecombinedtherapeuticeffect andimprovedrug targeting.Inthispaper,theexperimentalresearchonthecombinationofphotodynamicandimmunecheckpointinhibitors using nanotechnologyinthetreatmentofmalignanttumors isreviewed.Anditsclinicalapplicationis prospected.

KeyWords: photodynamic therapy; PD-1/PD-L1; CTLA-4; combination therapy; nano drug-carryingparticles

0 引言

恶性肿瘤一直是危害人体健康和生命的“罪魁祸首”,其发病率1逐年上升,因此寻找高效的治疗方法成为人们孜孜不倦探索的动力。(剩余37959字)

monitor
客服机器人